NURIX THERAPEUTICS IN
22.00
08-十月-24 15:59:59
15 分钟延时
股票
+0.46
+2.14%
今日范围
21.30 - 22.72
ISIN
N/A
来源
NASDAQ
-
20 3月 2024 09:40:00 条件 Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
11 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
06 3月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
05 3月 2024 16:30:00 条件 Nasdaq GlobeNewswire
-
15 2月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
01 2月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
16 1月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
08 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 1月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
07 11月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
02 11月 2023 09:00:01 条件 Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 Trial
01 11月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
12 10月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
31 8月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
13 7月 2023 16:01:00 条件 Nasdaq GlobeNewswire